Home
CStone Pharmaceuticals

CStone Pharmaceuticals Market Share Analysis for October 2026

基石药业（香港联交所代码: 2616）是一家生物制药公司，专注于研究开发及商业化创新肿瘤免疫治疗及精准治疗药物，以满足中国和全球癌症患者的殷切医疗需求。

Health > Biotechnology and Pharmaceuticals

Domaincstonepharma.com

Year Founded2015

Employees201 - 500

Annual Revenue$100M - $200M

CStone Pharmaceuticals

CStone Pharmaceuticals (including company regionals)

cstonepharma.com

See more website traffic and engagement information

CStone Pharmaceuticals Revenue up to October 2026 is 100M - 200M

revenue generated by CStone Pharmaceuticals top domains

CStone Pharmaceuticals top domains revenue over 3 years

Revenue for CStone Pharmaceuticals top domains

cstonepharma.com100M - 200M

See more with Sales Intelligence

Total visits to CStone Pharmaceuticals's top domains

Understand CStone Pharmaceuticals market share and potential market reach.

Total visits last 3 months

Subsidiaries Breakdown

cstonepharma.com4.8K

See more with Sales Intelligence

Avg. visit duration in CStone Pharmaceuticals's top domains

Analyze CStone Pharmaceuticals engagement metrics.

Average visit duration last 3 months

Subsidiaries Breakdown

cstonepharma.com00:00:09

See more with Sales Intelligence

Avg. pageviews on CStone Pharmaceuticals's top domains

See how CStone Pharmaceuticals keep users engaged, nurture their interest, and encourage them to take the next step.

Average page views last 3 months

Subsidiaries Breakdown

cstonepharma.com1.77

See more with Sales Intelligence

CStone Pharmaceuticals top competitors by domain

Looks like there’s not enough data here

No Data to Display

Top technologies used by CStone Pharmaceuticals

These are the website technologies, by industry, used by CStone Pharmaceuticals top domains

Advertising (1)

Baidu Ads

Business Solutions (1)

DocuSign

Conversion & Analytics (1)

Baidu Analytics

eCommerce (1)

Swap

More Technologies

4

See all

News & Signals from CStone Pharmaceuticals

With Similarweb Sales signals alerts, you’ll receive daily updates of recognized buying signals whenever new opportunities or threats arise in your target audience.

NewsCStone Pharma attends the European Society for Medical Oncology (ESMO) Congress 2026 on Oct 26th '26SUZHOU, China, Oct. 26, 2026 /PRNewswire/ - CStone Pharmaceuticals ("CStone," HKEX: 2616), an innovation-driven biopharmaceutical company focused on the research and development of therapies for oncology, immunology, inflammation, and other key disease areas, today announced a major clinical validation milestone for CS2009, its investigational PD-1/VEGF/CTLA-4 trispecific antibody, following two Rapid Oral presentations at the European Society for Medical Oncology (ESMO) Congress 2026.

NewsCStone Pharma reports $25.8M in revenue for Q2 '26Based on CStone Pharmaceuticals' latest earnings release for the quarter ending June 30, the company reported a quarterly revenue of HK$202.27 million and a GAAP net loss of HK$248.8 million.